Fanconi anemia complementation group N

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer	Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi anemia complementation group D1, Fanconi anemia complementation group N, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, central nervous system malformation, hereditary disease, hereditary sensory and autonomic neuropathy, inherited neurodegenerative disorder, male reproductive organ cancer, male reproductive system disorder, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, prostate cancer, prostate disorder	Recruiting	Phase 2	2026-09-17		NCT04038502
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies	Fanconi anemia complementation group D1, Fanconi anemia complementation group N, microphthalmia, syndromic 9	Recruiting	Phase 1	2026-09-02		NCT06458712

Clinical trials